Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis
Open accessThe DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index; 1 of the 50 sources its claims cite were checked for support.
Abstract
BACKGROUND: Despite its success with compliant or supervised patients, disulfiram has been a controversial medication in the treatment of alcoholism. Often, study designs did not recognize a pivotal factor in disulfiram research, the importance of an open-label design. Our objectives are: (1) to analyze the efficacy and safety of disulfiram in RCTs in supporting abstinence and (2) to compare blind versus open-label studies, hypothesizing that blinded studies would show no difference between disulfiram and control groups because the threat would be evenly spread across all groups. METHODS AND FINDINGS: We searched PubMed, EMBASE and the Cochrane Central Register for RCTs on disulfiram use with alcoholics in comparison to any alcoholic control group. The primary outcome was defined by the authors of each trial. Additional analyses included: blind vs. open-label, with or without supervision, cocaine study or not, and type of control. Overall, the 22 included studies showed a higher success rate of disulfiram compared to controls Hedges'g = .58 (95%CI = .35-.82). When comparing blind and open-label RCTs, only open-label trials showed a significant superiority over controls g = .70 (95%CI = .46-.93). RCTs with blind designs showed no efficacy of disulfiram compared to controls. Disulfiram was also more effective than the control condition when compared to naltrexone g = .77, 95%CI = .52-1.02, to acamprosate g = .76, 95%CI = .04-1.48, and to the no disulfiram groups g = .43, 95%CI = .17-.69. LIMITS INCLUDE: (1) a population of 89% male subjects and (2) a high but unavoidable heterogeneity of the studies with a substantial I-square in most subgroups of studies. CONCLUSIONS: Blinded studies were incapable of distinguishing a difference between treatment groups and thus are incompatible with disulfiram research. Based on results with open-label studies, disulfiram is a safe and efficacious treatment compared to other abstinence supportive pharmacological treatments or to no disulfiram in supervised studies for problems of alcohol abuse or dependence.
Overview
CoChat Summary
TL;DR
This meta-analysis found that disulfiram was superior to controls in open-label randomized trials, but not in blinded trials, suggesting that blinding masks the key expectancy mechanism of the drug. It also found more adverse events with disulfiram, but no difference from controls in deaths or serious adverse events requiring hospitalization.
Key findings
- Across 22 RCTs and 2,414 subjects, disulfiram had a higher success rate than controls: Hedges’ g = 0.58 (95% CI 0.35–0.82); heterogeneity was I² = 72%. After trim-and-fill correction, the effect remained significant: g = 0.47 (95% CI 0.24–0.71).
- In the blind/open-label subgroup analysis, open-label trials showed benefit: g = 0.70 (95% CI 0.46–0.93), while blinded trials showed no efficacy: g = 0.01 (95% CI −0.29–0.32).
- With supervision, disulfiram was significantly superior to controls: g = 0.82 (95% CI 0.59–1.05; I² = 46%); without supervision it was not significant: g = 0.26 (95% CI −0.02–0.53).
- Compared with specific controls, disulfiram was superior to naltrexone (g = 0.77), acamprosate (g = 0.76), and no disulfiram (g = 0.43). It also showed a higher adverse-events rate ratio of 1.40 (95% CI 1.01–1.94).
Methods
- Systematic review and meta-analysis of randomized controlled trials comparing oral disulfiram with any control group in alcohol-dependent/abusing patients; databases searched were PubMed, EMBASE, Cochrane Central Register, plus manual search (last searches June–November 2012).
- Final sample included 22 studies published from 1973 to 2010; total analyzed sample was 2,414 subjects, with some studies involving comorbid cocaine dependence.
- Main analysis used Hedges’ g under a random-effects model, with subgroup analyses by blinding, supervision, cocaine vs non-cocaine studies, and control condition, plus funnel plots, trim-and-fill, leave-one-out sensitivity analyses, and meta-regression.
Limitations
- The paper states that the included studies had a high and unavoidable heterogeneity with substantial I² in most subgroups, and that there was a possible publication bias suggested by funnel-plot asymmetry in the overall and open-label analyses.
- The paper states a sample composition limitation: 89% male subjects, so generalizability to women is limited.
- Evident from the text: many studies were methodologically weak by Cochrane criteria—among the 22 studies, 6 met none of the six risk-of-bias criteria, and only 2 met four—and many outcomes were based on differing primary endpoints across trials.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
1 Valid · 0 Not valid · 21 Not checked · 74 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Compliance has been a serious impediment in disulfiram research in numerous studies [26], [27].”
§ Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis > Introduction
What the sources say
- Supportedcites [26] HM Pettinati, 2008, A double blind, placebo-controlled trial that combines disulfiram and naltrexone for treating co-occurring cocaine and alcohol dependence, Addict Behav source
The Discussion states that taking fewer pills than prescribed 'has also been consistently reported in alcohol dependent populations for both disulfiram (Fuller, Rieckmann, McCarty, Smith et al., 2005)' and that 'typically disulfiram has had much higher nonadherence problems than naltrexone (De Witte et al., 2005; Fuller & Gordis, 2004; Suh et al., 2006)', i.e. a recurring problem credited to numerous studies. Results §3.2 adds that only 35.1% of patients received 80% or more of the possible disulfiram pills and that the modest adherence/exposure prevented meaningful post-hoc analyses of outcome, so compliance was indeed an impediment in this disulfiram trial. Together these support the paraphrase that compliance has been a serious impediment in disulfiram research. (LLM, conf=0.85)
- Not checked yetcites [27] RK Fuller, 1986, Disulfiram treatment of alcoholism. A Veterans Administration cooperative study, JAMA source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Disulfiram was also more effective than the control condition when compared to naltrexone g = .77, 95%CI = .52–1.02, to acamprosate g = .76, 95%CI = .04–1.48, and to the no disulfiram groups g = .43, 95%CI = .17–.69.”
§ Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis > Abstract > Methods and Findings
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Disulfiram was also more effective than the control condition when compared to naltrexone g = .77, 95%CI = .52–1.02, to acamprosate g = .76, 95%CI = .04–1.48, and to the no disulfiram groups g = .43, 95%CI = .17–.69.”
§ Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis > Abstract > Methods and Findings
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A visual inspection of the funnel plot revealed asymmetry, indicating a possible publication bias.”
§ Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis > Results > Disulfiram efficacy
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“I2 was 72%.”
§ Disulfiram Efficacy in the Treatment of Alcohol Dependence: A Meta-Analysis > Results > Disulfiram efficacy
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
51 more claims
Create a free account to see all 96 claims and to verify the 49 references still open.
- Probably not a substantial claim. 21
- It may state two separate claims as one. 24
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a meta-analysis of 22 studies, disulfiram demonstrated a higher success rate in promoting abstinence compared to placebo in open-label trials [52].”
From A Narrative Review of Current and Emerging Trends in the Treatment of Alcohol Use Disorder (2024) · cites this paper as [52]
Experimental — accuracy not yet measured
Citations
Cites
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,171
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962 · cited 1×
“Numerous studies have shown that the majority of patients who abuse cocaine also abuse alcohol, ranging from 50% to 90% [53,54,55,56,57,58].”
BackgroundAssessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396
Regier, D. A., Farmer, M. E., Rae, D. S., et al. (1990) · PubMed · Cited by 1,913
Disulfiram treatment of alcoholism. A Veterans Administration cooperative study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.256.11.1449 · Cited by 541
Disulfiram Treatment of Alcoholism: A Veterans Administration Cooperative Study
Fuller, R. K. (1986) · JAMA · doi:10.1001/jama.1986.03380110055026 · Cited by 431 · cited 10×
“In the larger study (n = 605) [27], only 20% of the 577 who completed the study were compliant.”
BackgroundInfluentialThe Development of a Questionnaire to Measure Severity of Alcohol Dependence *
Stockwell, T., Hodgson, R., Edwards, G., Taylor, C., & Rankin, H. (1979) · British Journal of Addiction to Alcohol & Other Drugs · doi:10.1111/j.1360-0443.1979.tb02415.x · Cited by 419
Carroll, K. M., Fenton, L. R., Ball, S. A., Nich, C., Frankforter, T. L., Shi, J., & Rounsaville, B. J. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.3.264 · Cited by 414 · cited 2×
“We were unable to obtain the baseline alcohol consumption for the sub sample of codependent patients in the Carroll et al study (2004) [43].”
MethodAlcoholism treatment by disulfiram and community reinforcement therapy
Azrin, N. H., Sisson, R. W., Meyers, R., & Godley, M. (1982) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(82)90050-7 · Cited by 411 · cited 2×
“Disulfiram has been used in the treatment of alcohol dependence with consistently successful results in individuals with high compliance or when medication intake has been directly supervised [1,2,3].”
BackgroundThe Status of Disulfiram: A Half of a Century Later
Suh, J. J., Pettinati, H. M., Kampman, K. M., & O'Brien, C. P. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000222512.25649.08 · Cited by 382 · cited 3×
“Indeed, if we postulate that the psychological threat of an aversive reaction is the pivotal mechanism of action of the drug as opposed to its actual pharmacodynamic properties when combined with alcohol, then there would be no chance of finding any difference between disulfiram and a control group in a double-blind d…”
BackgroundDobkin, P. L., Civita, M. D., Paraherakis, A., & Gill, K. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00083.x · Cited by 378 · cited 1×
“It has been shown that FSS can have a positive effect on the proportion of days abstinent [50] and can predict treatment retention and reduction of alcohol intake [51].”
BackgroundTreatment of cocaine and alcohol dependence with psychotherapy and disulfiram
Carroll, K. M., Nich, C., Ball, S. A., Mccance, E., & Rounsavile, B. J. (1998) · Addiction · doi:10.1046/j.1360-0443.1998.9357137.x · Cited by 375 · cited 5×
“In the Carroll et al (1998) five arm open study, also comparing different types of psychotherapy with disulfiram or with no disulfiram, we again extracted only the patients who were alcohol dependent from the combined disulfiram and no disulfiram groups.”
BackgroundMethodInfluentialDisulfiram Treatment of Alcoholism
Chick, J., Gough, K., Falkowski, W., Kershaw, P., Hore, B., Mehta, B., Ritson, B., Ropner, R., & Torley, D. (1992) · British Journal of Psychiatry · doi:10.1192/bjp.161.1.84 · Cited by 367
Jørgensen, C. H., Pedersen, B., & Tønnesen, H. (2011) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01523.x · Cited by 366 · cited 2×
“To date, one meta-analysis specifically on disulfiram has been conducted on disulfiram efficacy for the treatment of alcohol use disorder [19].”
BackgroundT⊘nnesen, H., Rosenberg, J., Nielsen, H. J., Rasmussen, V., Hauge, C., Pedersen, I. K., & Kehlet, H. (1999) · BMJ · doi:10.1136/bmj.318.7194.1311 · Cited by 283 · cited 1×
“Although Jorgensen et al proposed a meta-analysis on disulfiram efficacy, one non-efficacy study was included [20] and five eligible trials were absent [21,22,23,24,25].”
BackgroundConcurrent and simultaneous use of alcohol with cocaine: results of national survey
Grant, B. F., & Harford, T. C. (1990) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(90)90147-7 · Cited by 275 · cited 1×
“Numerous studies have shown that the majority of patients who abuse cocaine also abuse alcohol, ranging from 50% to 90% [53,54,55,56,57,58].”
BackgroundUpdate on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
Johnson, B. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.005 · Cited by 264 · cited 1×
“The highest success rates have been with patients who have chosen this type of treatment and are thus highly compliant or are receiving disulfiram under supervision [46].”
BackgroundDrug therapy for alcohol dependence
Swift, R. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401907 · Cited by 255 · cited 1×
“If alcohol is present, acetaldehyde accumulates [8,9] usually resulting in an unpleasant reaction, the disulfiram-ethanol reaction (DER), consisting primarily of tachycardia, flushing, nausea, and vomiting [8].”
BackgroundDisulfiram for the treatment of cocaine dependence
Pani, P. P., Trogu, E., Vacca, R., Amato, L., Vecchi, S., & Davoli, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007024.pub2 · Cited by 255 · cited 1×
“Disulfiram unexpectedly embarked upon a new career in the cocaine dependence treatment field [52].”
BackgroundDisulfiram treatment for cocaine dependence in methadone‐maintained opioid addicts
Petrakis, I. L., Carroll, K. M., Nich, C., Gordon, L. T., McCance‐Katz, E. F., Frankforter, T., & Rounsaville, B. J. (2000) · Addiction · doi:10.1046/j.1360-0443.2000.9522198.x · Cited by 228
McCance-Katz, E. F., Price, L. H., McDougle, C. J., Kosten, T. R., Black, J. E., & Jatlow, P. I. (1993) · Psychopharmacology · doi:10.1007/bf02257405 · Cited by 196 · cited 1×
“This can be explained by the effect of cocaethylene, a pharmacologically active metabolite that is produced when cocaine and alcohol are used together that enhances and prolongs cocaine euphoria [59].”
BackgroundGeneral and alcohol-specific social support following treatment
Beattie, M. C., & Longabaugh, R. (1999) · Addictive Behaviors · doi:10.1016/s0306-4603(98)00120-8 · Cited by 186 · cited 1×
“It has been shown that FSS can have a positive effect on the proportion of days abstinent [50] and can predict treatment retention and reduction of alcohol intake [51].”
BackgroundDisulfiram treatment of alcoholism
Wright, C., & Moore, R. D. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90534-k · Cited by 183 · cited 1×
“Disulfiram has been used in the treatment of alcohol dependence with consistently successful results in individuals with high compliance or when medication intake has been directly supervised [1,2,3].”
BackgroundDoes disulfiram have a role in alcoholism treatment today?
FULLER, R. K., & GORDIS, E. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00597.x · Cited by 182 · cited 2×
“Its mechanism of action for maintaining alcohol abstinence is thought to be primarily psychological [4,5,6,7] and based on a highly disagreeable pharmacological effect if alcohol is consumed.”
BackgroundNaltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders
Petrakis, I. L., Poling, J., Levinson, C., Nich, C., Carroll, K., & Rounsaville, B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.016 · Cited by 177 · cited 7×
“One study provided weekly clinical management compliance enhancement therapy [38].”
BackgroundResultInfluentialPsychopathology in Cocaine Abusers: Changing Trends
WEISS, R. D., MIRIN, S. M., GRIFFIN, M. L., & MICHAEL, J. L. (1988) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198812000-00004 · Cited by 175
Alcoholism in treatment-seeking cocaine abusers: clinical and prognostic significance.
Carroll, K. M., Rounsaville, B. J., & Bryant, K. J. (1993) · Journal of Studies on Alcohol · doi:10.15288/jsa.1993.54.199 · Cited by 169 · cited 1×
“Numerous studies have shown that the majority of patients who abuse cocaine also abuse alcohol, ranging from 50% to 90% [53,54,55,56,57,58].”
BackgroundDisulfiram treatment of alcoholism. A Veterans Administration cooperative study.
Fuller, R. K., Branchey, L., Brightwell, D. R., Derman, R., Emrick, C. D., Iber, F. L., James, K. E., Lacoursiere, R. B., Lee, K. K., & Lowenstam, I. (1986) · PubMed · Cited by 166
The efficacy of disulfiram: a review of outcome studies
HUGHES, J. C., & COOK, C. C. H. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb03370.x · Cited by 162 · cited 3×
“Some authors have gone so far as to state that unsupervised administration is of limited utility [17,47,48].”
BackgroundMedication treatment of different types of alcoholism
Johnson, B. A. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.08101500 · Cited by 151 · cited 2×
“Its mechanism of action for maintaining alcohol abstinence is thought to be primarily psychological [4,5,6,7] and based on a highly disagreeable pharmacological effect if alcohol is consumed.”
BackgroundLaaksonen, E., Koski-Jännes, A., Salaspuro, M., Ahtinen, H., & Alho, H. (2008) · Alcohol and Alcoholism · doi:10.1093/alcalc/agm136 · Cited by 147 · cited 3×
“Four of these compared disulfiram to naltrexone and to one other condition: to no disulfiram [13], to acamprosate [22,40], or to GHB [41].”
BackgroundDisulfiram for the Treatment of Alcoholism: An Evaluation in 128 Men
FULLER, R. K., & ROTH, H. P. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-6-901 · Cited by 132 · cited 6×
“In most studies, subjects were recruited from a center in which they were undergoing treatment for alcohol dependence [22,23,24,33,35,36,37,38,39] or seeking treatment and recruited through the media [10,26,31,34,40,41].”
BackgroundInfluentialMechanisms of Disulfiram-induced Cocaine Abstinence: Antabuse and Cocaine Relapse
Gaval-Cruz, M., & Weinshenker, D. (2009) · Molecular Interventions · doi:10.1124/mi.9.4.6 · Cited by 109 · cited 1×
“Several studies have proposed that cocaine use is reduced in subjects taking disulfiram because disulfiram inhibits dopamine beta-hydroxylase (DBH) and the consequent reduction of synaptic norepinephrine release alters the ‘‘high’’ [13,14,15,16].”
BackgroundA one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence
DE SOUSA, A., & DE SOUSA, A. (2004) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh104 · Cited by 108
An open randomized study comparing disulfiram and acamprosate in the treatment of alcohol dependence
DE SOUSA, A., & DE SOUSA, A. (2005) · Alcohol and Alcoholism · doi:10.1093/alcalc/agh187 · Cited by 107
Yao, L., Fan, P., Arolfo, M., Jiang, Z., Olive, M. F., Zablocki, J., Sun, H.-L., Chu, N., Lee, J., Kim, H.-Y., et al. (2010) · Nature Medicine · doi:10.1038/nm.2200 · Cited by 97
Pettinati, H. M., Kampman, K. M., Lynch, K. G., Xie, H., Dackis, C., Rabinowitz, A. R., & O′Brien, C. P. (2008) · Addictive Behaviors · doi:10.1016/j.addbeh.2007.11.011 · Cited by 95 · cited 6×
“In the Pettinati et al (2008) double-blind, four arm study, similar comparisons were made.”
BackgroundMethodResultInfluentialDisulfiram Maintenance in Outpatient Treatment of Alcoholism
Gerrein, J. R. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750360034004 · Cited by 94 · cited 8×
“The breakdown by gender was not available in a sub sample of two studies in which we analyzed only the arms of the study that were related to our research question [14,25].”
BackgroundInfluentialDoes disulfiram help to prevent relapse in alcohol abuse?
Brewer, C., Meyers, R. J., & Johnsen, J. (2000) · CNS Drugs · doi:10.2165/00023210-200014050-00001 · Cited by 92 · cited 3×
“Disulfiram has been used in the treatment of alcohol dependence with consistently successful results in individuals with high compliance or when medication intake has been directly supervised [1,2,3].”
BackgroundAn open randomized trial comparing disulfiram and topiramate in the treatment of alcohol dependence
Sousa, A. A. D., Sousa, J. D., & Kapoor, H. (2007) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2007.05.012 · Cited by 88 · cited 3×
“In the five Indian studies [24,33,35,36,37], family members were asked to supervise, but there was no real method to verify this supervision.”
BackgroundMethodCarroll, K., Ziedonis, D., O'Malley, S., McCance-Katz, E., Gordon, L., & Rounsaville, B. (1993) · American Journal on Addictions · doi:10.3109/10550499309115944 · Cited by 83
Pharmacologic approaches to the management of alcoholism.
Anton, R. F. (2001) · PubMed · Cited by 79
Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents
NIEDERHOFER, H., & STAFFEN, W. (2003) · Drug and Alcohol Review · doi:10.1080/0959523031000154436 · Cited by 75 · cited 5×
“Two studies evaluated adolescents (mean age 17) [33,34], one evaluated an older population (.”
BackgroundInfluentialOliveto, A., Poling, J., Mancino, M. J., Feldman, Z., Cubells, J. F., Pruzinsky, R., Gonsai, K., Cargile, C., Sofuoglu, M., Chopra, M. P., et al. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.07.022 · Cited by 70 · cited 1×
“Because we did not obtain a response from the fifth author [30], we were unable to include their trial.”
BackgroundRecent developments in the pharmacotherapy of alcohol dependence.
Schuckit, M. A. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.64.4.669 · Cited by 66 · cited 1×
“Other authors noted the more common problems of skin rash, halitosis, and fatigue [63].”
BackgroundDisulfiram treatment of alcoholism. A Veterans Administration cooperative study
Fuller, R. K., Branchey, L., Brightwell, D. R., Derman, R. M., Emrick, C. D., Iber, F. L., James, K. E., Lacoursiere, R. B., Lee, K. K., Lowenstam, I., et al. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198702000-00020 · Cited by 54
Malcolm, R., Olive, M. F., & Lechner, W. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.4.459 · Cited by 51 · cited 1×
“In alcoholics who also abused cocaine, the side effects reported were similar to those reported with the alcoholic only population [65].”
ResultDiehl, A., Ulmer, L., Mutschler, J., Herre, H., Krumm, B., Croissant, B., Mann, K., & Kiefer, F. (2010) · Alcohol and Alcoholism · doi:10.1093/alcalc/agq017 · Cited by 49
Grassi, M., Cioce, A., Giudici, F., Antonilli, L., & Nencini, P. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.11.005 · Cited by 48 · cited 6×
“Several studies have proposed that cocaine use is reduced in subjects taking disulfiram because disulfiram inhibits dopamine beta-hydroxylase (DBH) and the consequent reduction of synaptic norepinephrine release alters the ‘‘high’’ [13,14,15,16].”
BackgroundInfluentialLiver Toxicity Encountered in the Veterans Administration Trial of Disulfiram in Alcoholics
Iber, F. L., Lee, K., Lacoursiere, R., & Fuller, R. (1987) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1987.tb01312.x · Cited by 40 · cited 1×
“Iber et al studied liver toxicity in the Fuller et al (1986) study by analyzing the changes in liver status of 605 alcoholics [64].”
Comparing Treatments of Alcoholism on Craving and Biochemical Measures of Alcohol Consumptions
Nava, F., Premi, S., Manzato, E., & Lucchini, A. (2006) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2006.10399846 · Cited by 39 · cited 2×
“Four of these compared disulfiram to naltrexone and to one other condition: to no disulfiram [13], to acamprosate [22,40], or to GHB [41].”
BackgroundLing, W. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790070041005 · Cited by 31 · cited 7×
“The subjects were alcohol dependent in 18 of the studies and diagnosed as alcohol abuse or dependent in the other four studies [14,22,31,32].”
BackgroundInfluentialAn open randomized trial comparing disulfiram and naltrexone in adolescents with alcohol dependence
De Sousa, A., & De Sousa, A. (2008) · Journal of Substance Use · doi:10.1080/14659890802305861 · Cited by 29 · cited 4×
“Two studies evaluated adolescents (mean age 17) [33,34], one evaluated an older population (.”
BackgroundMethodInfluentialBrewer, C. L., & Streel, E. (2003) · Substance Abuse · doi:10.1080/08897070309511545 · Cited by 29 · cited 1×
“As described by Brewer and Streel (2003), refraining from alcohol consumption is a learning process and requires intentionally becoming alcohol intolerant through exposure and response prevention [45].”
BackgroundDisulfiram in severe alcoholism–an open controlled study
Ulrichsen, J., Nielsen, M. K., & Ulrichsen, M. (2010) · Nordic Journal of Psychiatry · doi:10.3109/08039481003686180 · Cited by 26 · cited 6×
“Eleven studies contained two arms comparing disulfiram to either placebo [14,32,34], to no disulfiram [23,42], to naltrexone [21,24,33,35], to acamprosate [36], or to topiramate [37].”
BackgroundInfluentialDisulfiram, an Option for the Treatment of Pathological Gambling?
Mutschler, J., Fauth‐Bühler, M., Grosshans, M., Diehl, A., Mann, K. F., & Kiefer, F. (2010) · Alcohol and Alcoholism · doi:10.1093/alcalc/agp093 · Cited by 24 · cited 1×
“On the other hand, different pharmacodynamic rather than psychological mechanisms of action have been proposed to explain the success of disulfiram in cocaine addiction [9,10,11], and in one case report of pathological gambling [12].”
BackgroundPATTERNS OF COMPLIANCE AND EVASION IN TREATMENT PROGRAMMES WHICH INCLUDE SUPERVISED DISULFIRAM
(1986) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a044645 · Cited by 23 · cited 1×
“Some authors have gone so far as to state that unsupervised administration is of limited utility [17,47,48].”
BackgroundFunctional Social Support within a Medical Supervised Outpatient Treatment Program
Mutschler, J., Eifler, S., Dirican, G., Grosshans, M., Kiefer, F., Rössler, W., & Diehl, A. (2012) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2012.677889 · Cited by 23 · cited 3×
“A recent study has shown that FSS is associated with a higher cumulative abstinence [49].”
BackgroundDISULFIRAM, COCAINE, AND ALCOHOL: TWO OUTCOMES FOR THE PRICE OF ONE?
Gossop, M., & Carroll, K. M. (2006) · Alcohol and Alcoholism · doi:10.1093/alcalc/agl003 · Cited by 18 · cited 1×
“On the other hand, different pharmacodynamic rather than psychological mechanisms of action have been proposed to explain the success of disulfiram in cocaine addiction [9,10,11], and in one case report of pathological gambling [12].”
BackgroundEffect of the threat of a disulfiram–ethanol reaction on cue reactivity in alcoholics
Skinner, M. D., Coudert, M., Berlin, I., Passeri, E., Michel, L., & Aubin, H.-J. (2010) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2010.06.011 · Cited by 17
Self-citationThe Role of Alcohol in Cocaine Dependence
Khalsa, H. K., Paredes, A., & Anglin, M. D. (1992) · Recent developments in alcoholism · doi:10.1007/978-1-4899-1648-8_1 · Cited by 17 · cited 1×
“Numerous studies have shown that the majority of patients who abuse cocaine also abuse alcohol, ranging from 50% to 90% [53,54,55,56,57,58].”
BackgroundWeinshenker, D. (2010) · Nature Medicine · doi:10.1038/nm0910-969 · Cited by 15 · cited 2×
“On the other hand, different pharmacodynamic rather than psychological mechanisms of action have been proposed to explain the success of disulfiram in cocaine addiction [9,10,11], and in one case report of pathological gambling [12].”
BackgroundDisulfiram implantation: a dose response trial.
Wilson, A., Blanchard, R., Davidson, W. J., McRae, L. P., & Maini, K. (1984) · PubMed · Cited by 14
Alcohol and cocaine abuse. A comparison of epidemiology and clinical characteristics.
Closser, M. H., & Kosten, T. R. (1992) · PubMed · Cited by 9
Closser, M. H., & Kosten, T. R. (1992) · Recent Developments in Alcoholism · doi:10.1007/978-1-4899-1648-8_6 · Cited by 8
The Relative Safety of Disulfiram
Alharbi, F., & el‐Guebaly, N. (2012) · Addictive Disorders & Their Treatment · doi:10.1097/adt.0b013e3182625beb · Cited by 8
Basic and clinical science of substance related disorders
Sundram, S. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2000.0841f.x · Cited by 5
von Bardeleben, U., Knoch, H., Biedert, E., et al. (1999) · Bibliotheca psychiatrica · doi:10.1159/000059537 · Cited by 4 · cited 6×
“Although Jorgensen et al proposed a meta-analysis on disulfiram efficacy, one non-efficacy study was included [20] and five eligible trials were absent [21,22,23,24,25].”
BackgroundInfluential
Research works printed but not linked: 2
- A De Sousa, 2009, An open label trial of naltrexone versus disulfiram in elderly patients with alcohol dependence, JPPS, 6, 85
- K Carroll, 2004, Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients, Archives of General Psychiatry, 61, 264, 10.1001/archpsyc.61.3.264 · DOI · Paper page
Cited by
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
Advances in the science and treatment of alcohol use disorder
Witkiewitz, K., Litten, R. Z., & Leggio, L. (2019) · Science Advances · doi:10.1126/sciadv.aax4043 · Cited by 592
Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review
Kranzler, H. R., & Soyka, M. (2018) · JAMA · doi:10.1001/jama.2018.11406 · Cited by 580
Connor, J. P., Haber, P. S., & Hall, W. D. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00122-1 · Cited by 389
Hazardous drinking and alcohol use disorders
MacKillop, J., Agabio, R., Feldstein Ewing, S. W., Heilig, M., Kelly, J. F., Leggio, L., Lingford-Hughes, A., Palmer, A. A., Parry, C. D., Ray, L., et al. (2022) · Nature Reviews Disease Primers · doi:10.1038/s41572-022-00406-1 · Cited by 215
“Notably, evidence of the effectiveness of disulfiram has been strongest in trials using witnessed or otherwise supervised administration (such as in collaboration with a spouse or partner), with limited benefits in unwitnessed administration 274,275 , due to low medication compliance.”
Metadata
- Authors
- Skinner, M. D., Lahmek, P., Pham, H., & Aubin, H.-J.
- Affiliations
- Inserm (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Université Paris-Sud (FR)
- Corresponding author
- Skinner, Marilyn D.
- ORCID
- Aubin, Henri-Jean
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-02-10
- Volume
- 9
- Issue
- 2
- Pages
- e87366
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3919718
- OpenAlex
- W2135168571
- Cited by
- 347
- References
- 71
- Citations by year
- 2026: 24 · 2025: 21 · 2024: 43 · 2023: 51 · 2022: 28 · 2021: 31 · 2020: 26 · 2019: 37 · 2018: 23 · 2017: 18 · 2016: 23 · 2015: 20 · 2014: 2
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
- Keywords
- disulfiram, alcoholism, alcoholism treatment, abstinence, naltrexone, acamprosate, supervised treatment, cocaine use, treatment efficacy, drug safety
- MeSH terms
- Adolescent, Adult, Aged, Alcohol Deterrents, Alcoholism, Cocaine, Disulfiram, Female, Humans, Male, Middle Aged, Case-Control Studies, Randomized Controlled Trials as Topic, Treatment Outcome, Endpoint Determination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.